dc.contributor.author | Warris, Adilia | |
dc.contributor.author | Lehrnbecher, Thomas | |
dc.contributor.author | Roilides, Emmanuel | |
dc.contributor.author | Castagnola, Elio | |
dc.contributor.author | Bruggemann, Roger J. M. | |
dc.contributor.author | Groll, Andreas H. | |
dc.date.accessioned | 2020-05-30T23:06:21Z | |
dc.date.available | 2020-05-30T23:06:21Z | |
dc.date.issued | 2019-09 | |
dc.identifier.citation | Warris , A , Lehrnbecher , T , Roilides , E , Castagnola , E , Bruggemann , R J M & Groll , A H 2019 , ' ESCMID-ECMM guideline : diagnosis and management of invasive aspergillosis in neonates and children ' , Clinical Microbiology and Infection , vol. 25 , no. 9 , pp. 1096-1113 . https://doi.org/10.1016/j.cmi.2019.05.019 | en |
dc.identifier.issn | 1198-743X | |
dc.identifier.other | PURE: 144385393 | |
dc.identifier.other | PURE UUID: af5eb782-9701-4ccc-a919-497d0bcaecff | |
dc.identifier.other | Scopus: 85067697628 | |
dc.identifier.other | Mendeley: 5073cf82-27cb-323c-892e-cdb6a6fe9f2b | |
dc.identifier.other | ORCID: /0000-0001-6586-3358/work/58864087 | |
dc.identifier.other | WOS: 000481643000008 | |
dc.identifier.uri | https://hdl.handle.net/2164/14403 | |
dc.description | ACKNOWLEDGEMENT Prof Warris is supported by the Wellcome Trust Strategic Award (grant 097377) and the MRC Centre for Medical Mycology (grant MR/N006364/1) at the University of Aberdeen. FUNDING European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the European Confederation of Medical Mycology (ECMM) | en |
dc.format.extent | 18 | |
dc.language.iso | eng | |
dc.relation.ispartof | Clinical Microbiology and Infection | en |
dc.rights | © 2019. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0 | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject | antifungal prophylaxis | en |
dc.subject | antifungal therapy | en |
dc.subject | aspergillosis | en |
dc.subject | neonates,children | en |
dc.subject | Antifungal therapy | en |
dc.subject | Neonates | en |
dc.subject | Aspergillosis | en |
dc.subject | Antifungal prophylaxis | en |
dc.subject | Children | en |
dc.subject | BRONCHOALVEOLAR LAVAGE GALACTOMANNAN | en |
dc.subject | POPULATION PHARMACOKINETIC ANALYSIS | en |
dc.subject | CHRONIC GRANULOMATOUS-DISEASE | en |
dc.subject | EMPIRICAL ANTIFUNGAL THERAPY | en |
dc.subject | BETA-D-GLUCAN | en |
dc.subject | LIPOSOMAL AMPHOTERICIN-B | en |
dc.subject | PEDIATRIC CANCER-PATIENTS | en |
dc.subject | POLYMERASE-CHAIN-REACTION | en |
dc.subject | ITRACONAZOLE ORAL SOLUTION | en |
dc.subject | STEM-CELL TRANSPLANTATION | en |
dc.subject | RJ Pediatrics | en |
dc.subject | Microbiology (medical) | en |
dc.subject | Infectious Diseases | en |
dc.subject | Medical Research Council (MRC) | en |
dc.subject | MR/N006364/1 | en |
dc.subject | Wellcome Trust | en |
dc.subject | 097377 | en |
dc.subject.lcc | RJ | en |
dc.title | ESCMID-ECMM guideline : diagnosis and management of invasive aspergillosis in neonates and children | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.MRC Centre for Medical Mycology | en |
dc.contributor.institution | University of Aberdeen.Institute of Medical Sciences | en |
dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Postprint | en |
dc.description.version | Postprint | en |
dc.identifier.doi | https://doi.org/10.1016/j.cmi.2019.05.019 | |
dc.date.embargoedUntil | 2020-05-31 | |
dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85067697628&partnerID=8YFLogxK | en |
dc.identifier.url | https://linkinghub.elsevier.com/retrieve/pii/S1198743X19302824 | en |
dc.identifier.url | http://www.mendeley.com/research/escmidecmm-guideline-diagnosis-management-invasive-aspergillosis-neonates-children | en |
dc.identifier.url | http://europepmc.org/abstract/med/31158517 | en |
dc.identifier.vol | 25 | en |
dc.identifier.iss | 9 | en |